Takeshi Saito Selected Research

N- 4- nitrobenzo- 2- oxa- 1,3- diazoleaminocaproyl sphingosylphosphorylcholine

1/2010

Activation of ceramidase and ceramide kinase by vanadate via a tyrosine kinase-mediated pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Saito Research Topics

Disease

26	Neoplasms (Cancer) 01/2021 - 01/2002
25	Infections 02/2022 - 03/2002
12	Neuroblastoma 10/2020 - 05/2005
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021 - 12/2002
10	Sepsis (Septicemia) 12/2020 - 01/2005
8	Biliary Atresia 11/2021 - 09/2007
8	Poisoning 01/2020 - 05/2007
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 03/2002
7	Virus Diseases (Viral Diseases) 10/2019 - 04/2006
6	Cysts 03/2022 - 09/2008
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 02/2005
5	Leukemia 03/2021 - 04/2002
5	Pancreaticobiliary Maljunction 08/2017 - 03/2008
5	Lymphoma (Lymphomas) 07/2010 - 01/2002
4	Liver Diseases (Liver Disease) 03/2022 - 02/2005
4	Fibrosis (Cirrhosis) 01/2021 - 04/2002
4	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2003
4	Pathologic Constriction (Stenosis) 02/2019 - 06/2009
4	Cataract (Cataracts) 12/2016 - 01/2012
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2009 - 10/2006
3	Vesicular Stomatitis 02/2022 - 01/2020
3	Hemorrhage 01/2022 - 03/2015
3	Hepatitis 01/2022 - 07/2004
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2013
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 02/2007
3	Inflammation (Inflammations) 01/2020 - 01/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2017 - 08/2002
3	Rectal Neoplasms (Rectal Cancer) 11/2016 - 11/2014
3	Breast Neoplasms (Breast Cancer) 10/2016 - 07/2003
3	Substance-Related Disorders (Drug Abuse) 12/2013 - 11/2004
2	Abscess 01/2022 - 02/2013
2	Hypersensitivity (Allergy) 01/2022 - 10/2016
2	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2021
2	Vascular Diseases (Vascular Disease) 07/2021 - 02/2019
2	Multiple Myeloma 01/2020 - 12/2018
2	Glioma (Gliomas) 01/2020 - 06/2012
2	Iron Overload 07/2019 - 05/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2019 - 06/2003
2	Brain Ischemia (Cerebral Ischemia) 02/2019 - 09/2011

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2021 - 04/2002
9	Antiviral Agents (Antivirals)IBA 01/2021 - 02/2007
7	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2007
7	Pharmaceutical PreparationsIBA 01/2020 - 06/2005
7	Biological ProductsIBA 02/2018 - 05/2005
7	Polymyxin B (Aerosporin)FDA LinkGeneric 12/2009 - 01/2005
6	InterferonsIBA 10/2019 - 02/2007
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 05/2005
5	phytobacteriomycin (PBM)IBA 08/2017 - 03/2008
5	Oxygen (Dioxygen)IBA 08/2008 - 08/2005
4	CholesterolIBA 01/2022 - 03/2020
4	CytokinesIBA 06/2017 - 01/2008
4	CatecholaminesIBA 12/2009 - 10/2006
3	Glycoproteins (Glycoprotein)IBA 02/2022 - 01/2020
3	AntigensIBA 01/2022 - 04/2004
3	AntibodiesIBA 01/2022 - 03/2016
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2010
3	LipopolysaccharidesIBA 12/2020 - 12/2009
3	AcidsIBA 07/2020 - 06/2012
3	TeaIBA 01/2020 - 05/2011
3	SteroidsIBA 01/2019 - 01/2002
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2018 - 02/2002
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2017 - 04/2002
3	Crystallins (Crystallin)IBA 12/2016 - 12/2013
3	CreatinineIBA 08/2016 - 06/2013
3	Messenger RNA (mRNA)IBA 12/2015 - 02/2004
3	Indicators and Reagents (Reagents)IBA 04/2012 - 04/2005
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2011 - 02/2007
3	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2011 - 12/2002
3	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2008 - 02/2007
2	Micafungin (FK463)FDA Link 09/2022 - 03/2011
2	Amylases FDA Link 03/2022 - 12/2013
2	Phenylalanine (L-Phenylalanine)FDA Link 02/2022 - 10/2019
2	Amino Acids FDA Link 02/2022 - 12/2013
2	Monoclonal AntibodiesIBA 01/2022 - 04/2002
2	LipidsIBA 01/2022 - 01/2020
2	Hemagglutinins (Hemagglutinin)IBA 12/2021 - 01/2020
2	Interferon Regulatory FactorsIBA 01/2021 - 07/2015
2	ArsenicIBA 10/2020 - 04/2018
2	ResveratrolIBA 03/2020 - 03/2017
2	ProdrugsIBA 01/2020 - 06/2012
2	Caffeine (No Doz)FDA LinkGeneric 01/2020 - 01/2020
2	FlavonesIBA 01/2020 - 01/2015
2	protoporphyrin IXIBA 01/2020 - 06/2012
2	nobiletinIBA 01/2020 - 01/2015
2	Deferasirox FDA Link 07/2019 - 05/2018
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2019 - 07/2002

Therapy/Procedure

25	Therapeutics 01/2022 - 01/2002
12	Drug Therapy (Chemotherapy) 09/2022 - 12/2002
8	Hemoperfusion 12/2009 - 01/2005
7	Cell Transplantation 11/2021 - 05/2018
7	Stem Cell Transplantation 07/2019 - 04/2002
5	Transplantation 03/2022 - 07/2002
5	Liver Transplantation 11/2021 - 09/2007
4	Decompression 09/2011 - 02/2004
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2021 - 04/2004
3	Catheters 01/2020 - 09/2011
3	Radiotherapy 11/2014 - 07/2003
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 02/2016
2	Hematopoietic Stem Cell Transplantation 01/2020 - 04/2017